Carregant...
Denosumab for the Treatment of Osteoporosis
INTRODUCTION: Low trauma fractures due to osteoporosis are a major health concern worldwide. Despite the availability of many therapeutic compounds to reduce fracture risk, osteoporosis remains undertreated and the burden of osteoporotic fractures remains high. Denosumab is a novel agent that acts t...
Guardat en:
| Publicat a: | Expert Opin Drug Metab Toxicol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4480604/ https://ncbi.nlm.nih.gov/pubmed/25614274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/17425255.2015.1000860 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|